|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-9-29
|
|
pubmed:abstractText |
This randomized, double-blind, placebo- and positive-controlled 4-way crossover study evaluated the effects of tapentadol immediate release (IR) on the QT/QTc interval.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0946-1965
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
678-87
|
|
pubmed:meshHeading |
pubmed-meshheading:20875374-Adult,
pubmed-meshheading:20875374-Aged,
pubmed-meshheading:20875374-Analgesics,
pubmed-meshheading:20875374-Cross-Over Studies,
pubmed-meshheading:20875374-Double-Blind Method,
pubmed-meshheading:20875374-Electrocardiography,
pubmed-meshheading:20875374-Female,
pubmed-meshheading:20875374-Humans,
pubmed-meshheading:20875374-Male,
pubmed-meshheading:20875374-Middle Aged,
pubmed-meshheading:20875374-Phenols,
pubmed-meshheading:20875374-Receptors, Opioid, mu
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects.
|
|
pubmed:affiliation |
Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ, USA. coh2@its.jnj.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
